After twelve months, eight patients and 2,052 sessions spread over 1,958 hours, Duke University is publishing some promising results from a study seeking to demonstrate the ability for brain-machine interfaces to help restore mobility in humans.
The study, which appeared this week in Scientific Reports, looked at a group of paraplegic patients suffering from a chronic spinal cord injury. The system utilized a brain-machine interface featuring an Oculus Rift headset that simulated the effect of having a neurological connection to their lower limbs. The system was also capable of moving a pair of robotic actuators to actually create movement. Continue Reading »
Published: August 8, 2016 | Category:News | Spinal Cord Injury:T-6
ReWalk Robotics announced the first ruling by the Social Welfare Court of Speyer which declared the ReWalk exoskeleton system was medically necessary and should be covered by insurance for a patient with spinal cord injury. The ruling, delivered in late July, overturns the original denial of the claim by the payer, a statutory health insurance entity, according to a press release.
The claimant, Philip Hollinger, is a 44-year-old man who sustained a spinal cord injury in a car accident in 2006. The accident left him paralyzed with a T6 level injury. Continue Reading »
Cumming School study first in Canada to examine whether using robotic device immediately following injuries promotes recovery
Researchers from the University of Calgary’s Cumming School of Medicine are the first in Canada to examine the benefits of using an exoskeleton robotic device to rehabilitate patients with spinal cord injuries (SCI) in the days and weeks following their injury. Continue Reading »
First robotic exoskeleton cleared for use with stroke and spinal cord injury levels to C7
RICHMOND, Calif., April 04, 2016 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Ekso GT robotic exoskeleton for use in the treatment of individuals with hemiplegia due to stroke, individuals with spinal cord injuries at levels T4 to L5, and individuals with spinal cord injuries at levels of T3 to C7 (ASIA D), in accordance with device’s labeling. The Ekso GT is the first exoskeleton cleared by the FDA for use with stroke patients. Continue Reading »
LOS ANGELES — There are tiny rat treadmills in the lab. And jars of Nutella, also for the rats. There are video cameras, heaps of electrodes, and instruments for slicing frozen brain tissue.
And in the center of it all: Reggie Edgerton, a 75-year-old physiologist who has spent four decades on a stubborn quest to prove, in the face of scientific ridicule, that severed spinal cords can be jolted back to life — and that paralyzed patients need not be paralyzed forever.
After inventing the first-ever untethered bionic exoskeleton, he broke from his former company. Now this inventor is back with another breakthrough.
The man behind the first untethered bionic exoskeleton is back with a new robotic suit.
Homayoon Kazerooni led the team that developed BLEEX, the first viable actuated suit that didn’t need to be plugged in, back in 2005. Groundbreaking at the time, the technology was eventually spun off into Ekso Bionics, long a darling of the Bay Area hardware scene. Continue Reading »
Injuries to the spinal cord partially or completely disrupt the neural pathways between the brain and the limbs. The consequences for the representation of the affected limbs in the brain can be drastic. Researchers have now measured how severely this representation is affected.
A strange sensation, but familiar to anyone who has ever been given local anaesthesia and watched while a doctor operated on their leg or arm: in that moment, your own body part seems foreign, as if it doesn’t belong to your body. One reason for this is that the brain still knows which position the limb occupied before the local anaesthetic took effect. As soon as it wears off, the spooky sensation disappears. Continue Reading »
State-of-the-Art Device Allows Individuals with Spinal Cord Injury to Stand and Walk; Regulatory Clearances in USA and Europe Pave the Way for Commercialization
CLEVELAND, March 10, 2016 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that the U.S. Food and Drug Administration (FDA) has given clearance to market and sell the Indego® exoskeleton for clinical and personal use in the United States. The company intends to commercially launch the device in the United States in the coming months. Continue Reading »
American insurance providers are being faced with an interesting health care debate: Should walking be considered a need?
At the center of this debate are exoskeletons — motorized devices that allows those with spinal cord injuries to stand upright and walk. So far, the ReWalk system is the only exoskeleton in the United States that has been approved by the FDA. However, it costs close to $70,000.